Results 161 to 170 of about 88,412 (297)
Cladribine tablets are approved for relapsing multiple sclerosis, mediating their clinical effect by moderately depleting lymphocytes. In a prospective, monocentric study including 22 patients completing 2 annual cycles of cladribine, B‐ and T‐cell receptor repertoires and relapse activity were assessed at baseline and after 24 months. T‐cell clonality
Tilman Schneider‐Hohendorf +8 more
wiley +1 more source
Case Report: Transient severe T cell lymphopenia in a patient with Cornelia de Lange Syndrome captured by TREC screening. [PDF]
Retif H +5 more
europepmc +1 more source
The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. [PDF]
Cerilli, GJ +4 more
core +1 more source
ABSTRACT Background This study evaluated the efficacy and safety of mecapegfilgrastim for preventing immunochemotherapy‐induced neutropenia in treatment‐naive patients with diffuse large B‐cell lymphoma (DLBCL). Methods In this open‐label, multicenter exploratory trial, patients were randomized in a 2:1 ratio to receive mecapegfilgrastim or no ...
Jie Wang +15 more
wiley +1 more source
La enfermedad por el virus del Ébola es una dolencia con frecuencia fatal, causada por una de las cinco cepas altamente contagiosas de este virus que afecta, tanto a animales como a seres humanos, cuya tasa de letalidad puede llegar al 90 %.
Juan Carlos Jaime Fagundo +3 more
doaj
Maintenance therapy for metastatic non-squamous non-small cell lung cancer: efficacy and biomarker analysis of pemetrexed discontinuation. [PDF]
Lin Y +13 more
europepmc +1 more source
ABSTRACT Both fruquintinib and TAS‐102 monotherapies are guideline‐recommended for third‐line treatment of metastatic colorectal cancer (mCRC). This study aimed to analyze the preliminary outcomes of fruquintinib combined with TAS‐102, with or without stereotactic body radiation therapy (SBRT), as a third‐ or later‐line therapy for mCRC.
Yi Wang +19 more
wiley +1 more source
Diabetes, Obesity and Metabolism, Volume 28, Issue 6, Page 5379-5383, June 2026.
Theodora Papanikolaou +5 more
wiley +1 more source
ABSTRACT Neoadjuvant immunochemotherapy (NIC) has emerged as a promising strategy for esophageal squamous cell carcinoma (ESCC). However, its impact on tertiary lymphoid structures (TLSs) and the immune microenvironment remains to be fully elucidated. We retrospectively analyzed 50 ESCC patients treated with NIC (n = 25) or chemotherapy alone (n = 25 ...
Ning Li +7 more
wiley +1 more source
Clinical Considerations of Splenic Dose Constraints to Mitigate Radiation-Induced Lymphopenia. [PDF]
Ma Y +8 more
europepmc +1 more source

